MedTrace Logo

Effect of Surgical Therapy on RANKL/OPG (Osteoprotegerin) System

NCT02190773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2014-07-15

No results posted yet for this study

Summary

In the present clinical study including chronic, aggressive periodontitis and healthy individuals, the investigators aimed to determine the RANKL, osteoprotegrin (OPG), Interleukin-1 (IL-1β), IL-10, IL-1β levels in gingival crevicular fluid(GCF) before and after surgical periodontal treatment and search out the relationship of clinical parameters with these cytokine levels.

Conditions

  • Chronic Periodontitis
  • Aggressive Periodontitis
  • RANKL/OPG Ratio
  • Gingival Crevicular Fluid

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02190773 on ClinicalTrials.gov